A synthesis of peptidylfluoromethanes is described that utilizes the conversion of phthaloyl amino acids into their fluoromethane derivatives. These can be deblocked and elongated. The inactivation of chymbtrypsin by Cbz-Phe-CH2F (benzyloxycarbonylphenylalanylfluoromethane) was found to be considerably slower than that of the analogous chloromethane. The fluoromethane analogue inactivates chymotrypsin with an overall rate constant that is 2% of that observed for the inactivation of the enzyme with the chloromethane.
INTRODUCTION
Since their introduction for the inactivation of chymotrypsin by affinity labelling (Schoellmann & Shaw, 1962; Ong et al., 1965) peptidyl-bromomethanes and -chloromethanes have been extensively studied. Variation of the amino acid sequence in the peptidyl portion provides affinity to individual serine proteinases whose specificities are satisfied, leading to the formation of a reversible complex and subsequent formation of a covalent bond. In serine proteinases this takes place at the active-centre histidine residue, residue 57 in the chymotrypsin sequence, and at the homologous histidine residue in trypsin, thrombin and plasmin as determined by structural analysis. This site of reaction is assumed to be general for other members of this family of proteinases. Cysteine proteinases are also irreversibly alkylated, but at the essential cysteine thiol group (Bender & Brubacher, 1966) .
Because variations in the peptide structure have led to selective and irreversible inactivators of proteinases of physiological importance as in blood coagulation and elastolytic degradation (Powers et al., 1977) , there has been hope that the variety of useful applications in vitro might lead also to applications in vivo. Only a few attempts have been made. The observation of some toxic effects on the repeated administration of one peptidylchloromethane (Ranga et al., 1981 ) may or may not reflect a general difficulty with this type of inhibitor. However, the reactivity towards thiol groups, whether in the form of GSH (Rossman et al., 1974) or in enzymes not related to proteolysis (Pong et al., 1975) , is probably an undesirable property, leading to multiple potentially harmful effects. Since the reactivity of chloromethyl ketones towards the activecentre histidine residue of serine proteinases is enhanced by at least 106-fold by the proximity effect due to inhibitor-enzyme-complex formation (Shaw & Ruscica, 1971) , it seemed attractive to examine fluoromethyl ketones in the hope that the greatly diminished nucleophilic displaceability of fluoride from such compounds might be overcome in enzyme complexes by proximity effects. However, side reactions with other molecules might be diminished owing to negligible rates, and the overall result would be an increase in selectivity. If the fluoride in such derivatives proved to be resistant to displacement even within an enzyme complex, conceivably the derivative could nevertheless be a useful proteinase inhibitor as the result of formation of a stable tetrahedral adduct of the active-centre serine hydroxy group to the carbonyl group of the reagent. This structural arrangement is found in the inhibited enzyme formed from trypsin and a substrate-like chloromethyl ketone (Malthouse et al., 1983 ), but may not depend on a displacement reaction, as shown by the work of Brodbeck et al. (1979) on the inhibition of acetylcholinesterase by fluorinated ketone substrate analogues.
Many attempts to synthesize peptidylfluoromethanes by displacement of chloride or bromide from peptidylhalomethanes by various forms of fluoride failed. Direct synthesis from a diazomethyl ketone by reaction with HF analogous to the rapid formation of bromomethyl or chloromethyl ketones (Schoellmann & Shaw, 1962; did not lead to fluorine-containing products. In the case of Cbz-Phe-CHN2, the use of HF/pyridine, a convenient source of HF (Olah et al., 1973) , provided mild conditions in which deblocking could be avoided, and permitted the isolation of a product for which an internally cyclized derivative involving the amide proton is the most likely structure. This reaction is known to occur upon treatment of (Imperiali & Abeles, 1986) .
EXPERIMENTAL Materials
Phthaloyl-Phe and phthaloyl-Ala were from Senn Chemicals, chromogenic and fluorogenic substrates were from Bachem, and tritiated acetic anhydride was from New England Nuclear. Cbz-Phe-Phe-CH2Cl and CbzPhe-Ala-CH2Cl were synthesized from the diazomethanes described earlier (Leary et al., 1977; Watanabe et al., 1979) . All other chemicals were from Fluka. Chymotrypsin (EC 3.4.21.1) (bovine, 3 x crystallized) from Sigma Chemical Co. was gel-filtered in 1 mM-HCl and freeze-dried. Cathepsin B (EC 3.4.22.1) was prepared from fresh pig liver as described by Evans & Shaw (1983) .
Methods
Inhibition studies with chymotrypsin. To determine the K1 of Cbz-Phe-CH2F, various amounts of an ethanolic 0.01 M solution of the inhibitor were added to a volume of 0.2 M-Tris/HCl buffer, pH 7.8, containing 0.1 M-NaCl and 0.01 M-CaCl2 such that a final volume of 1.0 ml was achieved after inclusion of substrate. This was 5 mmsuccinyl-Ala-Ala-Pro-Phe-p-nitroanilide (50 or 20 1 in the same buffer, depending on the final concentration desired). The (Tong & Elzinga, 1983) . We are grateful to Dr. Marshall Elzinga (Brookhaven 1986 (IV) National Laboratory, Upton, NY, U.S.A.) for these determinations.
Radiolabelled enzyme derivatives. Chymotrypsin (2.5 mg) in 0.1 M-Pipes/NaOH buffer, pH 7.0 (20 ml), was left at room temperature with ethanolic 10 mm-[aflacetyl-Phe-CH2F (0.8 ml) for 16 h. Activity fell to 13%. The solution was dialysed with four changes of 1 mm-HCl (4 litres) over a 48 h period. The sac contents were freeze-dried and the residue was taken up in 6 M-guanidinium chloride (0.4 ml). After 1 h, the solution was applied to a column (90 cm x 1.7 cm) of Sephadex G-75 equilibrated with 6M-guanidinium chloride and eluted with the same solvent at a flow rate of about 10 ml/h. Fractions (1.3 ml) were collected and the radioactivities of samples (0.2 ml) were counted by scintillation counting.
In the case of cathepsin B, 0.4 ml of a 7.6 /M solution of enzyme was treated with 20 u1 of 10 mm inhibitor, which provided a final concentration of 0.48 mm in 5% (v/v) ethanol. Samples (2,ul) were assayed. There was a 68% loss of activity in 90 min-with 90% loss upon standing overnight at 4 'C. The reaction was dialysed against 4-litre volumes of water until the diffusate was no longer radioactive (third change). At this point the sac contents accounted for 0.9 x 105 c.p.m., close to the expected value of 0.7 x 105c.p.m. This material was freeze-dried and the residue was gel-filtered as described above for chymotrypsin treated with the same inhibitor.
Determination of the operational molarity of cathepsin B solutions. The concentration of cathepsin B used in the present study was determined by titrating the enzyme with an accurately determined amount of the activesite-directed inhibitor D-Phe-Phe-Arg-CH2Cl .
Synthesis of peptidylfluoromethanes
Phthaloylphenylalanyldiazomethane (Ha). To phthaloylphenylalanine (6.5 g, 22 mmol) in tetrahydrofuran (110 ml) was added triethylamine (3.22 ml, 23.1 mmol) and isobutyl chloroformate (3.02 ml, 23.1 mmol) at -20 'C. After 15 min diazomethane (66 mmol) in diethyl ether was added. The reaction mixture was first stirred for 1 h at -20 'C, then for 1 h at room temperature. After the addition of water (100 ml) the reaction mixture was extracted with ethyl acetate; the organic phase was washed successively with satd. NaHCO3 and satd. NaCl and then dried over MgSO4, filtered and evaporated. Phthaloylphenylalanylfluoromethane (IIIa). A solution of 52% HF in pyridine (107.7 ml) was prepared by slow addition of pyridine (27.7 ml) to 70% HF in pyridine (80 ml) at 0 'C. After 10 min phthaloylphenylalanyldiazomethane (IIa) (6.4 g, 20 mmol) was added and the reaction mixture was stirred for 1 h at 0 'C, then 18 h at room temperature. The reaction mixture was neutralized by adding satd. NaHCO3 (600 ml) and solid NaHCO3. The solution was extracted twice with ethyl acetate (500 ml), the combined extracts were washed successively with 2 M-HCl (350 ml) and satd. NaCl (200 ml) and then dried over MgSO4, filtered and evaporated. The resulting oily solid was chromatographed over silica gel with chloroform/ethyl acetate (2:1, v/v), giving, after recrystallization from methylene chloride/hexane, colourless prisms (2.0 g, 33% yield), m. 3-Amino-l-fluoro-4-phenylbutan-2-ol (IVa). To phthaloylphenylalanylfluoromethane (lIla) (656 mg, 2.1 mmol) suspended in propan-1-ol/water (7:3, v/v) (21 ml) was added NaBH4 (398 mg, 10.5 mmol); solution was obtained after 10 min of stirring. After stirring for 16 h at room temperature, h.p.l.c. showed complete consumption of starting material. Acetic acid (2.2 ml) was added and the reaction mixture was heated at 80 'C for 7.5 h. The reaction mixture was then evaporated, and the residue was dissolved in water, basified with 2 M-NaOH to pH 10 and extracted with ethyl acetate. The organic phase was treated with water, and the aqueous phase was acidified to pH 1 with 1 M-HCl, separated, washed with ethyl acetate and then freeze-dried to give a colourless clear oil (390 mg, 85% yield).
3-(N-Benzyloxycarbonylamido)-l-fluoro-4-phenylbutan-2-ol (Va). To a solution of 3-amino-1-fluorophenylbutan-2-ol (IVa) (390mg, 1.78 mmol) -and NaHCO3 (596 mg, 7.10 Benzyloxycarbonylphenylalanylfluoromethane (VIa). To a solution of CrO3 (1.28 g, 12.8 mmol) and pyridine (2.06 ml, 25.6 mmol) in methylene chloride (32 ml) was added the alcohol (Va) (509 mg, 1.6 mmol, mixture of hydroxy isomers) in methylene chloride (5 ml). The reaction mixture was stirred for 16 h, and a further solution of CrO, (0.64 g, 6.4 mmol) and pyridine (1 ml, 12.8 mmol) in methylene chloride (16 ml) was added. After 45 min the reaction mixture was filtered through a short silica-gel column with ethyl acetate, and the solution was washed successively with 1 M-HCI and satd. NaCl, then dried over MgSO4, filtered and evaporated. The resulting oil, which partly solidified, was purified by chromatography through a silica-gel column with chloroform. Recrystallization from ethyl acetate/hexane gave colourless needles (103 Pyridine-SO3 adduct (159 mg, 1 mmol) was added to the alcohol (VIla) (89 mg, 0.31 mmol) and triethylamine (418 ,l, 3 mmol) in dimethyl sulphoxide (1.5 ml). After the mixture had been stirred for 19 h at room temperature ethyl acetate was added. The solution was washed with water, dilute KHSO4 (pH 2.6) until the aqueous phase was pH 2-3, satd. NaHCO3 and satd. NaCl, and then dried over MgSO4, filtered and evaporated. Purification on a silica-gel column with chloroform/methylene chloride (1:1, v/v) gave, after recrystallization from methylenechloride/hexane, colourless needles (44 mg, 50% yield), 63.93; H, 7.18; F, 6.88; N, 4.73; Cl, , H20FNO3 requires C, 64.04; H, 7.17; F, 6.76; N, 4.98% Stereospecific aspect of the fluoromethane synthesis During the synthesis of the fluoromethanes racemization can occur [Cbz-Phe-Phe-CH2F (Xa), Cbz-Phe-Ala-CH2F (Xb)], but not necessarily [Cbz-Phe-CH2F (VIa)], as indicated in the physical data of the oxidation products. The problem of the racemization was not further investigated in the present work.
RESULTS
The fluoromethyl ketones derived from the single amino acid, phenylalanine, were examined for their by Gel filtration of the product in 6 M-guanidinium chloride on Sephadex G-75 (90 cm x 1.7 cm) shows radioactivity in the protein peak (M) well resolved from the position of free inhibitor (A).
inhibitory effects on chymotrypsin. Of the series of derivatives described in the present paper, only these were considered likely to have inhibitory action on this enzyme. The dipeptide derivatives containing the Phe-Xaa sequence were expected to be substrates. Cbz-Phe-CH2F was the major candidate for study and provided a progressive loss of activity of chymotrypsin with time that was clearly slower than that by the corresponding chloromethyl ketone. gave a ti of about 2 min at 25°C (Shaw & Ruscica, 1971 ).
To relate this considerable difference in reactivity to differences in affinity or alkylation rate, an attempt was made to define the kinetic properties of Cbz-Phe-CH2F by utilizing the method of Kitz & Wilson (1962) . Reproducibility was poor, and such a comparative study was deferred. Because of the slow onset of irreversible action, it could also be readily studied as a reversible inhibitor by initial-velocity measurements made in the presence of succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (DelMar et al., 1979) . A Ki of 1.4 x 10-4 M was determined in this fashion by a Dixon plot (Fig. 1) . The progressive irreversible inactivation of chymotrypsin by the phenylalanylfluoromethanes is conceivably due to the relatively slow formation of a tight inhibitorenzyme complex. On the other hand, a displacement reaction involving the active-centre histidine-57 would lead to the same alkylated enzyme formed by the chloromethanes known to reveal a loss of histidine on amino acid analysis due to failure of His-57 to be regenerated from the alkyl derivative on acid hydrolysis (Schoellmann & Shaw, 1963) . In fact such a deletion was found in the case of inactivation by a fluoromethyl ketone, in which case the inhibited enzyme provided an arginine/histidine ratio of 3:1.2 compared with a ratio of 3:2 for uninhibited enzyme. Confirmatory evidence for covalent-bond formation was obtained in labelling experiments utilizing [3H]acetyl-Phe-CH2F. Chymotrypsin inactivated by this reagent retained its radioactivity after prolonged dialysis and also after gel filtration in 6 M-guanidinium chloride. The radioactivity was recovered in the protein peak (Fig. 2) typical of affinity-labelling reagents, and the pseudofirst-order decay of enzyme activity at pH 5.4 as a function of inhibitor concentration provided a KitzWilson plot indicative of formation of an intermediate complex (Fig. 3) . As expected from results with the corresponding diazomethyl ketones (Watanabe et al., 1979) , Cbz-Phe-Ala-CH2F was even more effective ( Fig. 4 and Table 1 ), owing to tighter binding. For comparison, Cbz-Phe-Phe-CH2Cl was also studied, and the results (Fig. 5 and Table 1 ) indicate that the reactivity of the peptidylfluoromethane is about half that of the corresponding peptidylchloromethane for cathepsin B if one compares the second-order rate constant for enzyme inactivation. The rate for covalent-bond formation is about one-fourth that of the chloromethane, but this is offset by tighter binding. As in the case of chymotrypsin, when the enzyme was inactivated with a radioactive form of a fluoromethane, the radioactivity was retained on gel filtration in 6 M-guanidinium chloride, appearing completely in the protein peak.
DISCUSSION
The observation that derivatives ofphenylalanylfluoromethane alkylate the active-centre histidine residue of chymotrypsin is a striking demonstration of the ability of affinity labelling to evoke chemical reactivity. It appears that in the series Cbz-Phe-CH2X the order of displaceability of fluoride will, at least in a qualitative sense, fall properly in a reactivity series containing other halides (Shaw & Ruscica, 1971) or departing groups susceptible to nucleophilic displacement (Larsen & Shaw, 1976) . However, we do not yet have adequate data to compare the relative alkylation rates or affinities of analogous reagents, for example Cbz-Phe-CH2Cl and the corresponding fluoro compound. The second-order rate constant for the inactivation of chymotrypsin by fluoromethyl ketone is about 1/40th that of the chloromethyl ketone at 25°C at pH 7, i.e. 117 M-1 mincompared with 4140 M-1 min-1 (Shaw & Ruscica, 1971) . Probably a large part of this difference is due to a lower rate for the covalent-bond-forming step. For Cbz-PheCH2Cl such information is not readily available because of the high reactivity, limitations of conventional spectroscopic methods and the generally poor affinity of chymotrypsin for typical ligands (Kurachi et al., 1973) . A quantitative comparison of the kinetic properties of fluoromethyl ketones and chloromethyl ketones as inactivators of serine proteinases can more readily be achieved with members of the trypsin-like family, including plasmin and thrombin, which have more affinity for small ligands than has chymotrypsin.
On the other hand, the present work and the observations by Rasnick (1985) provide, in the case of a cysteine proteinase, a comparison ofthe kinetic properties of a chloromethyl ketone and a fluoromethyl ketone. The Cbz-Phe-Phe derivatives were used in our case at 37°C, and the results (Table 1) are comparable with those reported by Rasnick (1985) obtained with the Cbz-PheAla derivatives at 28 'C. The fluoromethyl ketones are about 35-40% as effective as the chloromethyl ketones if one compares the second-order rates of enzyme inactivation. A lowered rate of covalent-bond formation is the cause of this difference, as expected. In the case of the Cbz-Phe-Phe derivatives, the fluoromethyl ketone alkylation rate was 0.26 times that of the chloromethyl ketone at 37 'C, but in the overall reactivity this was offset by tighter binding in the reversible phase (Table 1) . This pattern is qualitatively similar to the comparison of the Cbz-Phe-Ala derivatives examined by Rasnick (1985) . We also studied Cbz-Phe-Ala-CH2F at 37 'C, with results very similar to his; the differences can be attributed to the increased alkylation rate at the higher temperature used in our work. Finally, we observed that, when a radioactive fluoromethyl ketone was used to inactivate cathepsin B, the radioactivity was fullv retained under denaturing conditions, and, as in the case of chymotrypsin (Fig. 2) , appeared in the protein peak on gel filtration. Thus the inhibition is considered the result of modification of a typical affinity-labelling protein and not due to the formation of a tight-binding complex.
It is of interest that the rate of alkylation by fluoromethyl ketones compared with chloromethyl ketones is less depressed for the cysteine proteinase than for the serine proteinase by at least an order of magnitude.
In a study of the affinity labelling of triose-phosphate isomerase, Hartman (1971) showed that 1-halo-3-hydroxyacetone phosphates (iodo-, bromo-and chloro-) acting as analogues of the substrate dihydroxyacetone phosphate inactivated the enzyme irreversibly. Esterification of the active-centre glutamate side chain was shown to take place. In Fondy's laboratory, the fluoro analogue was obtained and was also found to inactivate triose-phosphate isomerase irreversibly, but the rate was about 1/ I000th that of the chloro compound (Silverman et al., 1975) . Presumably esterification of the enzyme was taking place in this case also.
Although peptidylfluoromethanes are less reactive than the corresponding chloro compounds, nevertheless their affinities appear to be at least as good, and thus they provide inhibition of a reversible nature just as effectively as the chloromethyl ketones, although the onset of the irreversible phase is delayed. For use in vivo Vol. 239 this may represent progress if diminished side reactions result in greater specificity and prolonged maintenance of inhibitor concentrations.
